Mergers & Acquisitions - Biotechnology

Filter

Current filters:

Biotechnology

Popular Filters

201 to 225 of 259 results

Theradiag acquires Prestizia and its MicroRNA technology platform

28-06-2012

Theradiag, (previously Biomedical Diagnostics), a Paris, France-based theranostics and in vitro diagnostics…

BiotechnologyMergers & AcquisitionsPrestiziaTheradiag

Compugen and Merck Serono set up biomarker company Neviah Genomics

25-06-2012

German drug major Merck KGaA's (MRK: DE) Merck Serono division and Israel-based Compugen (Nasdaq: CGEN)…

BiotechnologyCompugenMerck KGaAMerck SeronoMergers & AcquisitionsResearch

XTL Biopharma to acquire Kitov Pharmaceuticals

21-06-2012

Israeli biopharma firm XTL Biopharmaceuticals (TASE:XTL) says it will acquire fellow Israel-based Kitov…

BiotechnologyKitov PharmaceuticalsMergers & AcquisitionsPharmaceuticalXTL Biopharmaceuticals

Human Genome Sciences sets July 16 deadline for takeover bids

18-06-2012

In the latest update on UK pharma giant GlaxoSmithKline's (LSE: GSK) hostile takeover attempts for Human…

BiotechnologyGlaxoSmithKlineHuman Genome SciencesMergers & AcquisitionsPharmaceutical

Pharming considers options, including a sale of the company

13-06-2012

Netherland-based biotech company Pharming Group (NYSE Euronext: PHARM) yesterday revealed that it is…

BiotechnologyLicensingMergers & AcquisitionsPharmingRare diseasesResearchRuconest

Zacks analysts view progress of GSK bid for Human Genome Sciences

05-06-2012

UK pharma giant GlaxoSmithKline (LSE: GSK) recently announced that the waiting period with respect to…

BenlystaBiotechnologyGlaxoSmithKlineHuman Genome SciencesMergers & AcquisitionsPharmaceutical

NicOx drops its option to take full ownership of Altacor

04-06-2012

French biotechnology firm NicOx (NYSE Euronext Paris: COX) said last Friday that its board of directors…

AltacorBiotechnologyMergers & AcquisitionsNicOxOphthalmics

Sanofi's Aubagio reduces MS relapse; firm aims to build diabetes portfolio

01-06-2012

Genzyme, a subsidiary of French drug major Sanofi (Euronext: SAN) today reported top-line results from…

AubagioBiotechnologyDiabetesGenzymeMergers & AcquisitionsNeurologicalPharmaceuticalResearchSanofiteriflunomide

Israel's Thrombotech and D-Pharm to merge

25-05-2012

intellectual property developed and owned by Hadassah University Hospital, Israel's foremost medical…

BiotechnologyD-PharmHadasit Bio-HoldingsMergers & AcquisitionsThrombotech

French biotechnology a sector in need of new growth solutions

23-05-2012

The biotechnology industry in France is a dynamic sector mainly made up of small structures, but companies…

BiotechnologyEuropeFinancialMergers & Acquisitions

InterMune to divest Actimmune for $55 million; to focus on Esbriet

22-05-2012

California, USA-based biotech firm InterMune (Nasdaq: ITMN) says that it has reached a definitive agreement…

ActimmuneBiotechnologyEsbrietFinancialImmunologicalsInterMuneMergers & AcquisitionsRespiratory and PulmonaryVidara Therapeutics

Human Genome adopts Rights Plan to thwart GSK hostile takeover

18-05-2012

US biotech company Human Genome Sciences (Nasdaq: HGSI) said yesterday that, after carefully reviewing…

BiotechnologyGlaxoSmithKlineHuman Genome SciencesMergers & AcquisitionsPharmaceutical

GlaxoSmithKline buys full control of Cellzome

16-05-2012

UK pharma giant GlaxoSmithKline (LSE: GSK) has signed an agreement to fully acquire privately held Cambridge…

BiotechnologyCellzomeGlaxoSmithKlineMergers & AcquisitionsPharmaceutical

Amylin said to be attracting several Big Pharma suitors

16-05-2012

US biotech firm Amylin Pharmaceuticals (Nasdaq: AMLN), which earlier this year rebuffed a $22 per share…

AmylinAstraZenecaBiotechnologyBristol-Myers SquibbMerck & CoMergers & AcquisitionsPfizerPharmaceuticalRocheSanofiTakeda Pharmaceuticals

Empty pipelines drive deal valuations in pharmaceuticals sector, say IMAP

10-05-2012

A drought of domestic growth opportunities and new products is inflating valuations for R&D companies…

BiotechnologyMergers & AcquisitionsPharmaceuticalResearch

S&N launches new biologics firm, Bioventus, with focus on active orthopaedic healing

08-05-2012

Bioventus, a new company providing active orthopaedic healing, launched yesterday following the finalization…

Anti-Arthritics/RheumaticsBiotechnologyBioventusMarkets & MarketingMergers & AcquisitionsSmith & Nephew

Life sciences M&A activity heats Up in April, says Burrill & Co

07-05-2012

April proved to be a big month for M&A activity in the life sciences as companies announced more than…

BiotechnologyFinancialMergers & AcquisitionsPharmaceutical

Amylin operating loss leaps to over $30 million

27-04-2012

US biotech firm Amylin Pharmaceuticals (Nasdaq AMLN): reported financial results for the quarter ended…

AmylinBiotechnologyFinancialMergers & Acquisitions

Amgen acquires Turkish drugmaker Mustafa Nevzat for $700 million

26-04-2012

Global biotech giant Amgen (Nasdaq: AMGN) has reached agreement to acquire 95.6% of Mustafa Nevzat Pharmaceuticals…

AmgenBiotechnologyMergers & AcquisitionsMustafa Nevzat PharmaPharmaceutical

Biota and Nabi announce proposed merger

24-04-2012

Australian firm Biota Holdings (ASX: BTA) and USA-based Nabi Biopharmaceuticals (Nasdaq: NABI) yesterday…

Biota HoldingsBiota PharmaceuticalsBiotechnologyMergers & AcquisitionsNabi BiopharmaceuticalsPharmaceutical

201 to 225 of 259 results

Parexel

Parexel

Back to top